In Vitro, Ex Vivo and Clinical Trial of Brightening Serum Using a Novel Delivery System on Subjects With Moderate to Severe Dyschromia
The multiple active ingredients in CBS-TRV target melanogenesis in a variety of ways, and both in vitro and clinical studies demonstrated significant improvements in skin tone and pigmentation.
Authors
- T. Fleck (ORCID: https://orcid.org/0009-0003-9210-5212)
- Amir Moradi (ORCID: https://orcid.org/0000-0002-7307-8787)
- A Ortiz
- Swati Kannan
- Stacy J. Osborne
- Robert B. Love
- Ashish C. Bhatia
Institutions
- Northwestern University (US)
- UC San Diego Health System (US)
- Pacific Clinical Research (US)
- IS practice (BE)
- Neuroscience Education Institute (US)
Publication Details
- Journal
- Journal of Cosmetic Dermatology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/jocd.70686
- Primary Topic
- melanin and skin pigmentation
- Type
- article
- Field-Weighted Citation Impact
- 0.00